SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Mumtaz Mahal

PatientMumtaz Mahal
Date of birth1988-04-27
IdentifiersMRN HR-RE006-SYN; SSN (made up) 000-06-7184
Document date2026-02-03
AuthorFarzana Qureshi-Lindholm, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Prenatal visit at 17 weeks; maternal-fetal medicine consultation today. [S]

History of Present Illness

Mumtaz Mahal returns at 17 weeks 2 days. The cell-free DNA result came back low risk. She has taken ferrous sulfate every other morning for four weeks but has missed about half the doses because of nausea and constipation, and she is still tired and breathless on the stairs. She takes aspirin 81 mg at bedtime without bruising or bleeding, and folic acid. She has no headache, visual change, abdominal pain, bleeding, or urinary symptoms, and has begun to feel the baby move. She saw Dr. Montgomery-Rahimi of maternal-fetal medicine this morning. [S]

ElementDetail
ScreeningCell-free DNA low risk for trisomies 21, 18, and 13
IronAbout half of the oral iron doses taken; nausea and constipation
SymptomsTired; breathless on stairs; no bleeding, headache, or pain
Fetal movementFirst movements felt

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired by the afternoon
CardiovascularPositiveBreathless on stairs; no chest pain or palpitations
GastrointestinalPositiveNausea and constipation since starting iron
GenitourinaryNegativeNo bleeding, discharge, or urinary symptoms

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Folic acid 0.4 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-01-06activeS
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other dayOne tablet every other morning with water or orange juice, apart from tea and calciumOral route2026-01-06 to 2026-02-03completedS
Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtimeOne tablet by mouth at bedtime until deliveryOral route2026-01-06activeS
Ferric carboxymaltose 750 mg in 250 mL 0.9% sodium chloride, intravenous infusion over 15 minutes (first of two doses)Single infusion; two doses in total, four weeks apartIntravenous route2026-02-03 to 2026-02-03completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-02-03Body height157cmS
2026-02-03Body weight59.8kgS
2026-02-03Body mass index (BMI) [Ratio]24.3kg/m2S
2026-02-03Systolic blood pressure106mm[Hg]S
2026-02-03Diastolic blood pressure64mm[Hg]S
2026-02-03Heart rate86/minS
2026-02-03Respiratory rate14/minS
2026-02-03Body temperature36.6CelS
2026-02-03Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-03Hemoglobin [Mass/volume] in Blood10.3g/dL10.5-15 g/dLLowS
2026-02-03Ferritin [Mass/volume] in Serum or Plasma12ng/mL30-150 ng/mLLowS

Physical Exam

Vital signs recorded on 2026-02-03; see the Vital Signs section. [S]

SystemFinding
GeneralPale conjunctivae; well
AbdomenFundus midway between the pubic bone and the umbilicus; non-tender
FetalFetal heart 152 per minute by Doppler
Urine dipstickProtein negative

Problems

ProblemClinical statusVerificationCodeProvenance
Fourteenth pregnancy at 37 (gravida 14, para 13), single live intrauterine pregnancy dated by ultrasound at 13 weeks 2 days; estimated due date July 12activeconfirmed O09.529S — Synthetic modern prenatal care anchored to her documented fourteenth pregnancy; the dates are synthetic.
Grand multiparity: thirteen previous vaginal births, no cesarean or other uterine surgery; seven living childrenactiveconfirmed O09.40S — Synthetic modern problem anchored to her documented thirteen earlier births.
Short interpregnancy interval: conception about five and a half months after her last birthactiveconfirmed O09.899S — Synthetic modern problem anchored to the documented fourteen months between her last two births.
Iron deficiency anemia in pregnancy: hemoglobin 10.1 g/dL, MCV 76 fL, ferritin 9 ng/mLactiveconfirmed O99.019S — Synthetic finding; repeated pregnancies close together deplete iron. It echoes no documented diagnosis.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure and urine proteinEvery prenatal visitCompleted today106/64 mmHg; urine protein negative
ExaminationFetal heart and fundal heightEvery prenatal visitCompleted todayFetal heart 152 per minute; fundus midway to the umbilicus
ExaminationWeight gainEvery prenatal visitCompleted today59.8 kg, up 1.2 kg since intake
LaboratoryHemoglobin and ferritinAt intake, four weeks after starting treatment, at 24 to 28 weeks, and before deliveryCompleted todayHemoglobin 10.3 g/dL and ferritin 12 ng/mL after four weeks of oral iron; intravenous iron today
LaboratoryHemoglobin electrophoresisOnce, with microcytic anemia in a woman of South Asian heritageCompleted todayNormal; no thalassemia trait
LaboratoryFirst prenatal tests (blood group, antibody screen, rubella, hepatitis B, HIV, syphilis, hepatitis C, urine culture)At the first prenatal visitCompleted todayReviewed today: all normal or negative; RhD positive, so no anti-D is needed
LaboratoryCell-free DNA screeningFrom 10 weeks, as she choseCompleted todayLow risk for trisomies 21, 18, and 13
Medication safetyLow-dose aspirinDaily from 12 to 16 weeks until delivery; review at every visitCompleted todayTaken nightly since 13 weeks; no bruising or bleeding
ReferralMaternal-fetal medicine consultationEarly in a high-risk pregnancyCompleted todaySeen today; anemia, surveillance, and delivery planning agreed
ImagingDetailed anatomy scan with placental locationAt 18 to 22 weeksDueBooked for 21 weeks
LaboratoryGestational diabetes screenEarly with risk factors; again at 24 to 28 weeksUp to dateHemoglobin A1c 5.4 percent at intake; glucose challenge due at 24 to 28 weeks
SurveyPerinatal mood screen (EPDS)Each trimesterUp to date8 at intake, item 10 scored 0; next in the second trimester
Self-managementPostpartum hemorrhage risk assessment and birth planAt intake, in the third trimester, and on admission for birthUp to dateRisk factors so far: grand multiparity and anemia; detailed plan due in the third trimester

Goal progress:

Guideline basis: Pregnancy at Age 35 Years or Older: ACOG Obstetric Care Consensus No. 11 (2022); Practice Bulletin No. 183: Postpartum Hemorrhage (2017); Anemia in Pregnancy: ACOG Practice Bulletin, Number 233 (2021); Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020); Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021)

Follow-up: Prenatal visit with the anatomy scan at 21 weeks, when the second iron dose is due. Next scheduled visit 2026-03-03: prenatal visit at 21 weeks with the anatomy scan and placental location. [S]